NeuroMetrix announces 1-for-8 reverse stock split to regain Nasdaq bid price compliance

NeuroMetrix, Inc.

Reverse split effective 5:00 p.m. ET on Nov. 21, 2023; every 8 shares become 1 share.
Post-split shares outstanding approx. 1,091,675; authorized shares unchanged at 25 million.
Fractional shares paid in cash based on Nov. 21 closing price adjusted for split.
Ticker 'NURO' unchanged; new CUSIP 641255880; trading on Nasdaq continues on Nov. 22.
Split intended to lift per-share price above $1.00 minimum bid requirement for continued listing.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

NeuroMetrix, Inc.: Filed Certificate of Amendment to effect a 1-for-8 reverse stock split of common stock; authorized shares remain 25,000,000 (effective 2023-11-20).

Change: charter amendment
Effective: 2023-11-20

Exact text from the filing

On November 20, 2023, NeuroMetrix, Inc. (the "Company") filed with the Secretary of State of the State of Delaware a Certificate of Amendment to its Third Amended and Restated Certificate of Incorporation (the "Certificate of Amendment") to effect a one-time reverse stock split of the Company’s common stock, at a ratio of 1-for-8 (the "Reverse Stock Split").

View on SEC.gov

Browse all governance changes →

Source: SEC EDGAR

accession 0001628280-23-039571

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.